GABA(A) (gamma-aminobutyric acid(A)) receptors are molecular substrates for the regulation of vigilance, anxiety, muscle tension, epileptogenic activity and memory functions, which is evident from the spectrum of actions elicited by clinically effective drugs acting at their modulatory benzodiazepine-binding site. Here we show, by introducing a histidine-to-arginine point mutation at position 101 of the murine alpha1-subunit gene, that alpha1-type GABA(A) receptors, which are mainly expressed in cortical areas and thalamus, are rendered insensitive to allosteric modulation by benzodiazepine-site ligands, whilst regulation by the physiological neurotransmitter gamma-aminobutyric acid is preserved. alpha1(H101R) mice failed to show the sedative, amnesic and partly the anticonvulsant action of diazepam. In contrast, the anxiolytic-like, myorelaxant, motor-impairing and ethanol-potentiating effects were fully retained, and are attributed to the nonmutated GABA(A) receptors found in the limbic system (alpha2, alpha5), in monoaminergic neurons (alpha3) and in motoneurons (alpha2, alpha5). Thus, benzodiazepine-induced behavioural responses are mediated by specific GABA(A) receptor subtypes in distinct neuronal circuits, which is of interest for drug design.

Most fast inhibitory neurotransmission in the brain is mediated by GABAA receptors, which are mainly postsynaptic and consist of diverse alpha and beta subunits together with the gamma 2 subunit. Although the gamma 2 subunit is not necessary for receptor assembly and translocation to the cell surface, we show here that it is required for clustering of major postsynaptic GABAA receptor subtypes. Loss of GABAA receptor clusters in mice deficient in the gamma 2 subunit, and in cultured cortical neurons from these mice, is paralleled by loss of the synaptic clustering molecule gephyrin and synaptic GABAergic function. Conversely, inhibiting gephyrin expression causes loss of GABAA receptor clusters. The gamma 2 subunit and gephyrin are thus interdependent components of the same synaptic complex that is critical for postsynaptic clustering of abundant subtypes of GABAA receptors in vivo.

Benzodiazepine tranquilizers are used in the treatment of anxiety disorders. To identify the molecular and neuronal target mediating the anxiolytic action of benzodiazepines, we generated and analyzed two mouse lines in which the alpha2 or alpha3 GABAA (gamma-aminobutyric acid type A) receptors, respectively, were rendered insensitive to diazepam by a knock-in point mutation. The anxiolytic action of diazepam was absent in mice with the alpha2(H101R) point mutation but present in mice with the alpha3(H126R) point mutation. These findings indicate that the anxiolytic effect of benzodiazepine drugs is mediated by alpha2 GABAA receptors, which are largely expressed in the limbic system, but not by alpha3 GABAA receptors, which predominate in the reticular activating system.

Vigilance, anxiety, epileptic activity, and muscle tone can be modulated by drugs acting at the benzo- (Fig. la) was constructed containing a 6.4-kb genomic region including exons 7, 9, and 10 of the y2 subunit gene isolated from a 129SV mouse genomic library. A 1.2-kb genomic Pvu II-Nco I fragment including exon 8 (coding for amino acids 306-375 of the y2 polypeptide) was replaced with the phosphoglycerate kinase (PGK)-neo cassette (11), and a tk expression cassette (12) was added at the 3' end of the y2 sequence. Splicing from exon 7 to exon 9 would result in a stop of the translational reading frame and prohibit expression of sequences downstream of exon 7. Before electroporation into E14 ES cells (13), the plasmid was linearized at a polylinker site adjacent to the 5' end of the 7y2 genomic sequence. E14 ES cells were cultured on irradiated G418-resistant feeder cells obtained from CD1-M-TKneo2 mouse embryos [BRL, Fullinsdorf (Basel)] in GMEM (Glasgow modification of Eagle's medium; Flow Laboratories) containing 10% total calf serum and leukemia inhibitory factor (103 units/ml, Life Technologies). The cells were transfected and screened for homologous recombinants (14) by using PCR and the primers y2.19 (5'-CATCT CCATC GCTAA GAATG TTCGG derived from 7y2 sequences upstream of the targeting vector and Y2.20 (5'-ATGCT CCAGA CTGCC TTGGG AAAAG C-3') derived from PGK promoter sequences (11). Chimeric mice were generated (15) and mated to C57BL/6 females, and the offspring were genotyped by PtR amplification of tail DNAs. Reactions specific for the disrupted y2 allele [(0) Abbreviations: BZ, benzodiazepine; GABA, y-aminobutyric acid; DRG, dorsal root ganglion (ganglia); ES, embryonic stem; E, embryonic day; P, postnatal day.§To whom reprint requests should be addressed. 7749The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.